{"name":"Biomed Industries, Inc.","slug":"biomed-industries-inc","ticker":"","exchange":"","domain":"biomedindustries.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"immunology","drugs":[{"name":"Biological: oral polio vaccine","genericName":"Biological: oral polio vaccine","slug":"biological-oral-polio-vaccine","indication":"Poliomyelitis prevention in infants and children","status":"phase_3"},{"name":"Bionetide","genericName":"Bionetide","slug":"bionetide","indication":"Other","status":"phase_3"},{"name":"Comparable Placebo of drug","genericName":"Comparable Placebo of drug","slug":"comparable-placebo-of-drug","indication":"Control arm in Phase 3 clinical trials (indication depends on the active drug being tested)","status":"phase_3"},{"name":"Drug: Bionetide","genericName":"Drug: Bionetide","slug":"drug-bionetide","indication":"Other","status":"phase_2"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Drug: NA-831","genericName":"Drug: NA-831","slug":"drug-na-831","indication":"Type 2 diabetes","status":"phase_2"},{"name":"NA-831","genericName":"NA-831","slug":"na-831","indication":"Type 2 diabetes","status":"phase_3"}]}],"pipeline":[{"name":"Drug: NA-831","genericName":"Drug: NA-831","slug":"drug-na-831","phase":"phase_2","mechanism":"NA-831 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"Biological: oral polio vaccine","genericName":"Biological: oral polio vaccine","slug":"biological-oral-polio-vaccine","phase":"phase_3","mechanism":"Oral polio vaccine stimulates the immune system to produce antibodies against poliovirus types 1, 2, and 3 by delivering live attenuated (weakened) virus that replicates in the gastrointestinal tract.","indications":["Poliomyelitis prevention in infants and children"],"catalyst":""},{"name":"Bionetide","genericName":"Bionetide","slug":"bionetide","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Comparable Placebo of drug","genericName":"Comparable Placebo of drug","slug":"comparable-placebo-of-drug","phase":"phase_3","mechanism":"A placebo contains no active pharmaceutical ingredient and produces therapeutic effects solely through the placebo effect.","indications":["Control arm in Phase 3 clinical trials (indication depends on the active drug being tested)"],"catalyst":""},{"name":"Drug: Bionetide","genericName":"Drug: Bionetide","slug":"drug-bionetide","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"NA-831","genericName":"NA-831","slug":"na-831","phase":"phase_3","mechanism":"NA-831 is a small molecule drug that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxQd05mVkZEenpZendfZm9RMXhhSFRrbWIyYUROVUxzT2Q3QXhrSUw5SXllV2Y0TDcxUzdIektFSjhPSEtxMnNjM0tpenRWTzhpTjlPRWgxcmRVVEM4ZVZ1V0psMGc3aFc1eDJ4RUNtS2dOUzdZTU56WGhpSTd6cl9nZVRld1RNa3E3WlFXZVZ6eUNEekxkYlFtallsRXVvcE5DS3RIQVBYdldsTC1VMjdiZ1dxZ2VGYm05YWkxWGI3N1paUQ?oc=5","date":"2026-03-19","type":"regulatory","source":"CHEManager","summary":"CordenPharma Colorado Partners with BioMed Realty on Peptide Development Lab Expansion - CHEManager","headline":"CordenPharma Colorado Partners with BioMed Realty on Peptide Development Lab Expansion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwJBVV95cUxNbDhLcGdmakxSazM3WFNwTTBncTRZWGdsZHo1VXNGTVpJRzJKWGduQmVWem13RVlUZW1xM2VPbGxmeUFLMTBVR2Jid3hZeU55WU9Pb19PS1JzVzk1S1dXc1BZeVA0cl9tdGhLaDNFVVBBd08xM0UxQkd5Q0ZqSTFfRlNLWGJhZGxOVzdNQUhiMGUyTGJCa0oxUDdjUG5tUk9UVXJtd1Y5RGswb0xqcE4tTDhnOENNa0FCNHFiaWZwQWdZTFBOUFoxSDNER2hVbmRWcHVaeE9TOG5KMlFnYU1FMDlLaEFXcW5XUVE3ejJ0cVhzU09BblhHTXRDT0ktdDl2WVdTdGpqX0MyV1lxV2Y4?oc=5","date":"2026-03-13","type":"pipeline","source":"Morningstar","summary":"Native Collagen Market Outlook 2026-2036: Global Market to Reach USD 343.57 Million by 2036 at 4.2% CAGR | Future Market Insights, Inc. - Morningstar","headline":"Native Collagen Market Outlook 2026-2036: Global Market to Reach USD 343.57 Million by 2036 at 4.2% CAGR | Future Market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQR2tfZnNXd0VQSjlDOE5ESDh1ZW1BTGIyRFZOTlVrd2U3Q2FsZG9UYjJudEZjbGYzYXVTVHhNRTdXcnd4bzRTcV92UjhkbG9GZkxUNnpvUm1FMm9udG9xRHI4aFZuVmdHcHI4Ym5LRzJrYUlET1hjY0tFaUdqX3VkQWRBS0JEWTBhWjNmeU5vR3F4QlBW?oc=5","date":"2026-03-11","type":"pipeline","source":"Yahoo Finance","summary":"Corporate Update: Psyence BioMed Advances Vertically Integrated Pharmaceutical Platform Following PsyLabs Export Milestone - Yahoo Finance","headline":"Corporate Update: Psyence BioMed Advances Vertically Integrated Pharmaceutical Platform Following PsyLabs Export Milesto","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswJBVV95cUxPVDJnakRjSDF6ejloeGJraDRtUGxJUVBQLUExY1ktckRFa2d4aFBPSW91Q1EyeGVUSW9aVWRPam92TmhYTE14ak5BTmFpUVZ6MkRDcFlScTJNcjAxSTNsMEx0LVpnSUE1bU9HYVlnR09sWHNNV2lUTWRmZmhYakdMWDczZzlwX1p1YUw5MURBOHVJcGJ2S0hLcDZDWW9rOUJWd3c5UGxlMUJFeEU2TENmd2Y3UmQtXzJwdHpDRmJIdTc3U092QWloZkpwc29xRFctb2w4ZjFqOVZxeWhvTG1ULUhwMlBkc1JlRDhuTmZvOXotVjhJVURTNHlXYlZIamZIZ1FLbUlPVy1UaXItOVJfMXVBamhlM1FlRjVDOFlGVWwzVzRULUlGSnFFenZMZFdpemJn?oc=5","date":"2026-03-04","type":"pipeline","source":"businesswire.com","summary":"BioMed Realty and CordenPharma Colorado Team Up for Expansion of Peptide Development Lab in New LEED - businesswire.com","headline":"BioMed Realty and CordenPharma Colorado Team Up for Expansion of Peptide Development Lab in New LEED","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAJBVV95cUxQNTgyU3JWNTE0M09vOU5sREk4Sk5GTFNuUlVaYjg5eE9LYXFVU1ZiUHBlTHA3RmFPeTRYbTJyWFI1Y2hnWjAxZzBZemFPT2ZnalJxRkgtR2F0UG15OWZpNV9HU1NqZWZ0QUdOclYtVlowU3NScDBvYlJBX1JMUU1nX2Rja3NCak1rR1A1NnhYUVYwSkUzQjFXOThZaldldS10TklDOXhyamwxd2tha25CWkJnWUExOE5RYW96UGpPUE9FSlNpWC1LSGQtUXJFQkYxZnZQNlUwZlczaU92QmZFZVFDdTJXX3lLMGZ1Z19BQnZPWnNZTWxuNFRla1E1R1VUR3h4aUdJbGVobDE3?oc=5","date":"2026-03-01","type":"regulatory","source":"Visalia Times-Delta","summary":"Biomed Industries Advances NA-931 Into Two Global Phase 3 Trials Alone and with Semaglutide and Tirzepatide for Obesity - Visalia Times-Delta","headline":"Biomed Industries Advances NA-931 Into Two Global Phase 3 Trials Alone and with Semaglutide and Tirzepatide for Obesity ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8AJBVV95cUxPQldUazR6RnBoNFVyZ0hJS3E1Q2I1NEtNbjdqbGVsWjV6WUJneUc4bV9zZXpXNkdBYl84Sk1NTXY4blllQzFvTTdjLTJBYjQzRUJFRmpNRjh2bU13RFNlS1lwdFhCajdPbG41N1pOQV9tMU1qcGwzQ1Y1U1h1Y3lWRVhwQUNNMlRaTzQzZUFsUGhQcWRnRDRfWUo3bllzNkFMN0lzTDBZSUlkU0dTZUJKMndUS19uVnVqOFo2a0xzVVNQX19ma2dTbkJLNUhqdUZWR2ViNm41N3E5TUwtVHd4UTdTNjVoNnpsUEh5RVhLdlBrRkoyTVl2Q2hqemc1amhiM080U3NnU3lKaThfd2dLNG1CUTlpWFF5cGhnRVBWcTdfVjV0dlZERHFVSVVqQ1Zrd21XUTIwaGgxVWc4cmpQbXBtZUFCMDdTd3k5U19iTjdYV0E3XzY0S1lPNTY1ZElrWEI4dUlwOXVIRDZiU1VoOQ?oc=5","date":"2025-12-23","type":"pipeline","source":"GlobeNewswire","summary":"GLP-1 Agonists (Ozempic, Wegovy, Mounjaro) Market - Global - GlobeNewswire","headline":"GLP-1 Agonists (Ozempic, Wegovy, Mounjaro) Market - Global","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxQN2pCWDdhRENyTFpPQzU5XzFOYW1hRnY2NktsRndfMkx2TFUtYXVCV29FRWRwVnNmTXNTMF9la3RDb1R3UGdNaUhNc2RWbi1xSHhodWNVRmRQdmRKRzdycmFFTzZEeWhHRVNuYlFpTGF0Q285MzltdVVmNm1rSmZYM0wzRHg0UlFDRUs1SmVRMF9INlIxQ3B1NGZ0NWZtUkpj?oc=5","date":"2025-12-05","type":"pipeline","source":"Investor's Business Daily","summary":"Biotech Stocks Are Tumbling — But The Top 5 Are Standouts - Investor's Business Daily","headline":"Biotech Stocks Are Tumbling — But The Top 5 Are Standouts - Investor's Business Daily","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9fSE9QNm1qSFkzR2ZUOTNxSkRCNEJzall4X1RTMGQxdFFDZTVrY01kSkduWUR5VVRDUDFwb1h2cFloc0lrVUFzeFZodHJ3MXNjNjZMT1BFaTZISHdoRTBTT0RzV3dfNm0wOU1uZkRn?oc=5","date":"2025-11-19","type":"pipeline","source":"KED Global","summary":"Celltrion steps into weight-loss market with oral rival to Wegovy, Mounjaro - KED Global","headline":"Celltrion steps into weight-loss market with oral rival to Wegovy, Mounjaro","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-07-28","type":"pipeline","source":"South China Morning Post","summary":"GSK to pay Hengrui US$12.5 billion for global rights to 12 drug projects - South China Morning Post","headline":"GSK to pay Hengrui US$12.5 billion for global rights to 12 drug projects","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxOeG5KMmdyWTFGSDRpNk5vby1zVmEwV3hZZzhXcnNQME84aVh2R2Q0TmJWNDBOMXFFa05XMjQwbl9kaG1HRkJndUF5TmJ4eXBSejdyb3dXOVd2X2VTYkQ5bnhCWGNNeXp5SWltZUFDQWV0X09vUVdRbDI1YjVzRTgzOWlFUEJWY2FERUdRaGdmR0RfZjRVZ3BKNg?oc=5","date":"2025-07-26","type":"trial","source":"JLL","summary":"Life Science Industrial Park - development in Shanghai - JLL","headline":"Life Science Industrial Park - development in Shanghai","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQN2wzNFdHTDNla2x0M19VRTh3U3BPdzBjZGZIcU1XeWxlbnBMRzd4Q1N3U2dzcmNjS0tJMlFOa1N1YkxEWElaZWw4aFNLS2Y3MTY1LWdmUVdSaXdKdmc4cDY3WHNJSzFiSzNHbUx3SkpxUWtyVWYtMDQyUDJqSHVlYjcxb1VrcmVVc3FPXzRrZDc3Rmt0Wkp6cmFsSkwwMGl5U3UzS1k3d1hwZnBU?oc=5","date":"2025-06-27","type":"pipeline","source":"statnews.com","summary":"Proposed cuts could have ‘catastrophic effect,’ 110 biomedical, health sciences industry leaders tell Congress - statnews.com","headline":"Proposed cuts could have ‘catastrophic effect,’ 110 biomedical, health sciences industry leaders tell Congress","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxOS2NOcUJYX0RTMGNDNEM2a182YXVxZFRodVNrUVNPYmdmY3NfXzlLTnpEX1BsWWJCaldnaGVOS3FYNlFod21TZ2tURVZwdlhBbFRLcmlJOGdKYTRLbDYzaDczS2dFd1RxZGZxRXFCM01KWFpXQy1PSmNFNDNBSVBCQ3BDakRPS0RJeVFBdUR2REEwV0JCOEt1WVluRmtyN3pNNy1hcE94WTZpRDlmSlBUbHVwbzg1ZUhIUXc?oc=5","date":"2025-06-23","type":"deal","source":"Stock Titan","summary":"Global Pharma Merger: Dr Ashleys Takes Over NYSE-Listed Impact BioMedical to Fast-Track Drug Patents - Stock Titan","headline":"Global Pharma Merger: Dr Ashleys Takes Over NYSE-Listed Impact BioMedical to Fast-Track Drug Patents","sentiment":"neutral"}],"patents":[],"drugCount":6,"phaseCounts":{"phase_2":2,"phase_3":4},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}